Clinical Trial: A Multicenter Exploratory Clinical Study of Targeted NK Cell Inhibition for Transplant Kidney Chronic Active Antibody-Mediated Rejection (caABMR): Single Induction with CD38 Monoclonal Antibody Followed by Sequential Maintenance with Azathioprine (China)

China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter Exploratory Clinical Study of Targeted NK Cell Inhibition for Transplant Kidney Chronic Active Antibody-Mediated Rejection (caABMR): Single Induction with CD38 Monoclonal Antibody Followed by Sequential Maintenance with Azathioprine'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132756

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Zhejiang University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334443

Published by HT Digital Content Services with permiss...